Financière de Tubize SA (EBR:TUB)

Belgium flag Belgium · Delayed Price · Currency is EUR
225.40
+5.60 (2.55%)
Jun 26, 2026, 5:35 PM CET
69.47%
Market Cap 10.03B
Revenue (ttm) n/a
Net Income (ttm) 93.23M
Shares Out 44.51M
EPS (ttm) 2.09
PE Ratio 107.62
Forward PE n/a
Dividend 1.08 (0.48%)
Ex-Dividend Date May 7, 2026
Volume 14,943
Average Volume 32,620
Open 221.80
Previous Close 219.80
Day's Range 218.60 - 225.40
52-Week Range 128.80 - 250.50
Beta 0.40
RSI 55.32
Earnings Date Jul 24, 2026

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1928
Employees 3
Stock Exchange Euronext Brussels
Ticker Symbol TUB
Full Company Profile

Financial Performance

Financial Statements

News

Financière de Tubize Earnings Call Transcript: H2 2025

Maintains a 36% stake in UCB, focusing on long-term value and readiness to support UCB's growth, with strong stock price and TSR performance driven by UCB's key products. Dividend growth slowed to 4% as reserves are prioritized for strategic flexibility.

3 months ago - Transcripts

Financière de Tubize Annual report: H2 2025

Financière de Tubize has published its H2 2025 annual report on March 23, 2026.

3 months ago - Filings

Financière de Tubize Earnings release: H1 2025

Financière de Tubize released its H1 2025 earnings on August 1, 2025, summarizing the period's financial results.

11 months ago - Filings

Financière de Tubize Quarterly report: H1 2025

Financière de Tubize has published its H1 2025 quarterly earnings report on August 1, 2025.

11 months ago - Filings